stable-mates: sublobar resection vs sabr in high-risk patients with stage i nsclc
Published 3 months ago • 42 plays • Length 0:37Download video MP4
Download video MP3
Similar videos
-
1:51
outcomes of i-sabr in lung cancer
-
1:08
the future of i-sabr in lung cancer
-
7:25
surgery vs sabr
-
0:28
stereotactic ablative radiotherapy (sabr) for lung cancer treatment
-
2:18
stereotactic radiotherapy vs surgery in early-stage ncslc
-
30:26
session-6 “overview of sbrt in lung cancer.” by dr shyam part a
-
9:24
lung cancer – radiation therapy treatment
-
45:37
srs/sbrt - clinical targets and treatment planning i brain, spine, lung - by ning wen, ph.d
-
1:00
combining sabr and immunotherapies for nsclc
-
19:24
debate: optimal approach for stage i nsclc - sbrt
-
1:36
toxicities associated with combining stereotactic ablative radiotherapy (sabr) and immunotherapy
-
49:02
debate: sabr and limited resection in lung cancer
-
19:13
debate: surgery versus stereotactic body radiation therapy in early stage nsclc - surgery
-
3:14
the impact of stereotactic body radiation therapy on outcomes in nsclc
-
2:02
i-sabr: enhancing immunotherapy with stereotactic radiation
-
2:33
the use of single-fraction sbrt versus multi-fraction sbrt for lung cancers and metastases
-
3:07
pembrolizumab, sabr develop a rapport for oligometastatic rcc | shankar siva
-
14:21
sabr in borderline lung function
-
4:02
stereotactic body radiotherapy (sbrt) in nsclc
-
2:20
sabr improves outcomes for stage 1 lung cancer
-
3:54
introducing stereotactic ablative body radiotherapy (sabr)